TPL Inhibits the Invasion and Migration of Drug-Resistant Ovarian Cancer by Targeting the PI3K/AKT/NF-κB-Signaling Pathway to Inhibit the Polarization of M2 TAMs

Chemoresistance is the primary reason for the poor prognosis of patients with ovarian cancer, and the search for a novel drug treatment or adjuvant chemotherapy drug is an urgent need. The tumor microenvironment plays key role in the incidence and development of tumors. As one of the most important...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Fuyin, Yang, Lilan, Han, Yiwen, Zhong, Yanying, Zhan, Fuliang, Feng, Ying, Hu, Hui, Chen, Tingtao, Tan, Buzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350572/
https://www.ncbi.nlm.nih.gov/pubmed/34381726
http://dx.doi.org/10.3389/fonc.2021.704001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350572/
https://www.ncbi.nlm.nih.gov/pubmed/34381726
http://dx.doi.org/10.3389/fonc.2021.704001

Ejemplares similares